Why the study?
Patients with atrial fibrillation and high stroke risk who are unsuitable for oral anticoagulants require alternative stroke prevention strategies.
Does bilateral permanent percutaneous carotid artery filter placement provide safe and feasible stroke prophylaxis in atrial fibrillation patients unsuitable for oral anticoagulants?
Does bilateral permanent percutaneous carotid artery filter placement provide safe and feasible stroke prophylaxis in atrial fibrillation patients unsuitable for oral anticoagulants?
Bilateral permanent percutaneous carotid artery filter placement is a technically feasible and safe first-in-human approach for stroke prophylaxis in atrial fibrillation patients unsuitable for oral anticoagulation.
Answers are grounded in this paper and cite their sources.
Supports technical feasibility in small cohort; leaves open whether carotid filters reduce stroke in anticoagulation-ineligible AF.
BACKGROUND: Patients with high stroke risk and atrial fibrillation who are unsuitable to oral anticoagulants (OACs) require other stroke prevention strategies. A novel permanent coil filter directly placed into both common carotid arteries (CCAs) was designed to capture emboli >1.4 mm in diameter. OBJECTIVES: The multicenter, nonrandomized, first-in-human clinical CAPTURE (Carotid Artery Implant for Trapping Upstream Emboli for Preventing Stroke in Atrial Fibrillation Patients) trial sought to determine the feasibility and safety of bilateral CCA filter placement. Under ultrasound guidance, after direct transcutaneous carotid puncture with a 24-gauge needle, a motorized unit expels the filter to unfurl in the artery. Patients received aspirin/clopidogrel for 3 months, and aspirin thereafter. Primary endpoints were: 1) procedural success-bilateral, properly positioned CCA filters; and 2) 30-day incidence of major adverse events-death, stroke, major bleeding, filter migration, CCA thrombus, or stenosis. Carotid ultrasounds were conducted post-procedure, pre-discharge, at 1 week, and at 1, 3, 6, and 12 months. Procedure success was 92% (23 of 25 patients); 1 patient had unilateral deployment. There were no device/procedure-related major adverse events; minor puncture site hematomas/edema occurred in 5 of 25 (20%). After 6-month mean follow-up, asymptomatic thrombi were detected in 4 patients (1 bilateral, 4 unilateral), adjudicated as captured (n = 3), unclassified (n = 2), or in situ (n = 0). In all patients, the thrombi dissolved with subcutaneous heparin. In 1 patient, 2 device/procedure-unrelated minor strokes occurred. CONCLUSIONS: Permanent carotid filter placement for stroke prophylaxis is technically feasible and safe. (Carotid Artery Implant for Trapping Upstream Emboli for Preventing Stroke in Atrial Fibrillation Patients [CAPTURE]; NCT03571789).
No takes yet. Share an insight, caveat, or question.
Reddy et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: